Лекарственные взаимодействия
Betibeglogene autotemcel + Deferoxamine
Тяжесть: Тяжёлое
Betibeglogene autotemcel and Deferoxamine: major interaction.
Последнее обновление
Для специалистов здравоохранения — только для справки. Эта страница — краткая сводка, а не медицинская консультация и не замена официальной инструкции или клинического суждения. Всегда проверяйте перед назначением или отпуском.
Клиническое содержание этой страницы доступно только на английском языке.
Кратко
Some iron chelators can suppress bone marrow and may interfere with engraftment and hematologic recovery after gene therapy conditioning. Chelation around the time of myeloablation and infusion is therefore restricted.
Что означает это взаимодействие простыми словами
Betibeglogene autotemcel and Deferoxamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Почему это происходит
Potential additive myelosuppressive or marrow-impairing effects of chelators could compromise engraftment; deferoxamine itself is less myelosuppressive than some chelators, so the mechanism is not firmly established.
Что делать
Stop iron chelation at least 7 days before conditioning, and avoid myelosuppressive chelators for about 6 months after infusion. Use phlebotomy or a non-myelosuppressive chelator if iron reduction is needed.
О чём спросить фармацевта
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Для подписчиков Pro+
Откройте страницу целиком
Создайте аккаунт и начните пробный период Pro+, чтобы открыть полные рекомендации по ведению для Betibeglogene autotemcel и Deferoxamine, дополнительные примечания, подробности о доказательной базе и проверку взаимодействий для всего рецепта.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ бесплатно 14 дней на сайте. Карта не нужна.
Другие взаимодействия Deferoxamine
- Ascorbic acid + Deferoxamine Тяжёлое
- Deferoxamine + Exagamglogene autotemcel Тяжёлое
- Deferoxamine + Lovotibeglogene autotemcel Тяжёлое
- Deferoxamine + Vitamin c Тяжёлое
- Carbonyl iron + Deferoxamine Умеренное
- Deferoxamine + Ferrous fumarate Умеренное
Частые вопросы
Can I take Betibeglogene autotemcel with Deferoxamine?
MediHelp rates the interaction as major. Betibeglogene autotemcel and Deferoxamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Some iron chelators can suppress bone marrow and may interfere with engraftment and hematologic recovery after gene therapy conditioning. Chelation around the time of myeloablation and infusion is therefore restricted.
How serious is the interaction between Betibeglogene autotemcel and Deferoxamine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop iron chelation at least 7 days before conditioning, and avoid myelosuppressive chelators for about 6 months after infusion. Use phlebotomy or a non-myelosuppressive chelator if iron reduction is needed.
What other medicines interact with Deferoxamine?
MediHelp also lists interactions of Deferoxamine with, for example, Ascorbic acid, Exagamglogene autotemcel, Lovotibeglogene autotemcel. The full list is on the Deferoxamine page.
Полные монографии, дозировки и проверка взаимодействий в приложении MediHelp
Откройте полный справочник, проверяйте взаимодействия нескольких препаратов и пользуйтесь инструментами дозирования в приложении MediHelp.
